Funder: Gilead Sciences
Due Dates (Anticipated): November 2026 (Full application deadline, projected)
Funding Amounts: Up to $1,500,000 per collaborative grant; typical project period up to 36 months.
Summary: Supports collaborative, community-based initiatives advancing health equity in cancer care for underserved populations, with a focus on clinical trial access and patient-centered support.
Key Information: Collaborative proposals are required; U.S. applicants must be 501(c)(3) organizations serving disinvested communities.